Benjamin Bratt
Tanaka Capital Management Inc
Assets Managed
$59.887M
Holdings
43
Last Quarter
2026 - Q1
Filed Date
8d ago
Growth Rate
9.25%(2Q avg: 3.99%)
Sustained Growth
1 quarters
Portfolio positions
This chart displays the top 10 holdings in Tanaka Capital Management Inc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 43 positions.
Assets under management
The assets under management (AUM) of Tanaka Capital Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 59.887M in assets, with a quarterly growth rate of 9.25% and a 2-quarter average growth rate of 3.99%. The portfolio is managed by Benjamin Bratt, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
UAMY United States Antimony Corp
| 8.98% | $5.377M 615,975 shares@ $8.73 avg price | |
NXE Nexgen Energy Ltd
| 8.51% | $5.095M 439,205 shares@ $11.61 avg price | Decreased -0.77% |
CORT Corcept Therapeutics Inc
| 7.47% | $4.469M 110,854 shares@ $40.32 avg price | Decreased -0.2% |
NVDA Nvidia Corp
| 7.22% | $4.322M 24,780 shares@ $174.42 avg price | Decreased -0.12% |
ur-8⤦ Aura Minerals, Inc.
| 6.83% | $4.087M 50,085 shares@ $81.61 avg price | Increased 11.71% |
NUVB Nuvation Bio Inc
| 6.47% | $3.869M 901,825 shares@ $4.3 avg price | Increased 7.16% |
AAPL Apple Inc
| 5.45% | $3.263M 12,859 shares@ $253.76 avg price | Decreased -0.6% |
IJR Ishares Core S&p Small-cap E
| 4.74% | $2.836M 220,216 shares@ $12.88 avg price | Increased 132.16% |
CPRX Catalyst Pharmaceuticals Inc
| 4.69% | $2.808M 113,418 shares@ $24.76 avg price | Decreased -0.87% |
ONTO Onto Innovation Inc
| 4.27% | $2.553M 12,448 shares@ $205.1 avg price | Decreased -3% |
1-10 of 43